Integra LifeSciences (IART) PT Raised to $60 at Credit Suisse
Tweet
Share
E-mailGet Alerts IART Hot Sheet
Price: $17.29 +0.29%
Rating Summary:
8 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
8 Buy, 17 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Credit Suisse analyst Matt Miksic raised the price target on Integra LifeSciences (NASDAQ: IART) to $60.00 (from $58.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Edgewise Therapeutics (EWTX) PT Raised to $60 at JPMorgan
- Hims and Hers (HIMS) PT Lowered to $35 at Barclays
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
